CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $85M
- YoY, 2025
- +37.7%
- 5-year CAGR
- +20.3%
- 10-year CAGR
- +30.2%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $85M | +37.7% |
| 2024 | $61M | +25.4% |
| 2023 | $49M | +15.3% |
| 2022 | $42M | −1.1% |
| 2021 | $43M | +28.0% |
| 2020 | $34M | +14.4% |
| 2019 | $29M | +23.4% |
| 2018 | $24M | +77.7% |
| 2017 | $13M | +89.3% |
| 2016 | $7.1M | +17.4% |
| 2015 | $6.0M | +15.6% |
| 2014 | $5.2M | +0.1% |
| 2013 | $5.2M | −2.1% |
| 2012 | $5.3M | +54.6% |
| 2011 | $3.4M | +62.3% |
| 2010 | $2.1M | +17.6% |
| 2009 | $1.8M | — |